Table 3.
Comparison of efficacy between the two groups, n (%)
| Research group (n = 89) | Control group (n = 95) | χ2 | P value | |
| CR | 33 (37.08) | 20 (21.05) | ||
| PR | 35 (39.33) | 38 (40.00) | ||
| NC | 15 (16.85) | 22 (23.16) | ||
| PD | 6 (6.74) | 15 (15.79) | ||
| Cure rate (%) | 5.017 | 0.025 | ||
| 76.40 | 61.05 |
CR: The tumor focus completely disappeared and lasted for more than 4 wk; PR: The tumor focus was reduced by more than 50% and maintained for more than 4 wk, and no new lesions occurred; NC: The tumor volume was reduced by < 50%, increased by < 20% and maintained for more than 4 wk, and no new lesions were found; PD: The tumor focus increased by more than 20% and a new lesion appeared.